A retrospective analysis of etiology and outcomes of hemophagocytic lymphohistiocytosis in children and adults

BACKGRUOUND: Hemophagocytic lymphohistiocytosis (HLH) is a rare but severe, life-threatening inflammatory condition if untreated. We aimed to investigate the etiologies, outcomes, and risk factors for death in children and adults with HLH.

METHODS: The medical records of patients who met the HLH criteria of two regional university hospitals in Korea between January 2001 and December 2019 were retrospectively investigated.

RESULTS: Sixty patients with HLH (35 children and 25 adults) were included. The median age at diagnosis was 7.0 years (range, 0.1-83 years), and the median follow-up duration was 8.5 months (range, 0-204 months). Four patients had primary HLH, 48 patients had secondary HLH (20 infection-associated, 18 neoplasm-associated, and 10 autoimmune-associated HLH), and eight patients had HLH of unknown cause. Infection was the most common cause in children (14/35, 40.0%), whereas neoplasia was the most common cause in adults (13/25, 52.0%). Twenty-eight patients were treated with HLH-2004/94 immunochemotherapy. The 5-year overall survival (OS) rate for all HLH patients was 59.9%. The 5-year OS rates for patients with primary, infection-associated, neoplasm-associated, autoimmune-associated, and unknown cause HLH were 25.0%, 85.0%, 26.7%, 87.5%, and 62.5%, respectively. Using multivariate analysis, neoplasm-induced HLH (p=0.001) and a platelet count <50×109/L (p=0.008) were identified as independent risk factors for poor prognosis in patients with HLH.

CONCLUSION: Infection was the most common cause of HLH in children, while it was neoplasia in adults. The 5-year OS rate for all HLH patients was 59.9%. HLH caused by an underlying neoplasm or a low platelet count at the time of diagnosis were risk factors for poor prognosis.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:38

Enthalten in:

Yeungnam University journal of medicine - 38(2021), 3 vom: 06. Juli, Seite 208-218

Sprache:

Englisch

Beteiligte Personen:

Kwak, Abraham [VerfasserIn]
Jung, Nani [VerfasserIn]
Shim, Ye Jee [VerfasserIn]
Kim, Heung Sik [VerfasserIn]
Lim, Hyun Ji [VerfasserIn]
Lee, Jae Min [VerfasserIn]
Heo, Mi Hwa [VerfasserIn]
Do, Young Rok [VerfasserIn]

Links:

Volltext

Themen:

Hemophagocytic lymphohistiocytosis
Human herpesvirus 4
Journal Article
Lymphoproliferative disorders
Neoplasms
Survival

Anmerkungen:

Date Revised 24.04.2022

published: Print-Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.12701/yujm.2020.00591

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM318089335